| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.5 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |